A new trading day began on Monday, with RAPT Therapeutics Inc (NASDAQ: RAPT) stock price up 7.87% from the previous day of trading, before settling in for the closing price of $33.81. RAPT’s price has ranged from $5.67 to $42.39 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -10.10% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 90.49%. With a float of $17.87 million, this company’s outstanding shares have now reached $27.71 million.
RAPT Therapeutics Inc (RAPT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of RAPT Therapeutics Inc is 35.50%, while institutional ownership is 30.07%.
RAPT Therapeutics Inc (RAPT) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -9.76 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.66 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 90.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.74% during the next five years compared to -10.10% drop over the previous five years of trading.
RAPT Therapeutics Inc (NASDAQ: RAPT) Trading Performance Indicators
Here are RAPT Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -11.07, a number that is poised to hit -0.81 in the next quarter and is forecasted to reach -3.18 in one year’s time.
Technical Analysis of RAPT Therapeutics Inc (RAPT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.67 million. That was better than the volume of 0.22 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 45.53%.
During the past 100 days, RAPT Therapeutics Inc’s (RAPT) raw stochastic average was set at 82.40%, which indicates a significant increase from 72.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.63 in the past 14 days, which was higher than the 2.01 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $30.92, while its 200-day Moving Average is $16.24. However, in the short run, RAPT Therapeutics Inc’s stock first resistance to watch stands at $38.17. Second resistance stands at $39.86. The third major resistance level sits at $41.98. If the price goes on to break the first support level at $34.36, it is likely to go to the next support level at $32.24. The third support level lies at $30.55 if the price breaches the second support level.
RAPT Therapeutics Inc (NASDAQ: RAPT) Key Stats
With a market capitalization of 1.01 billion, the company has a total of 27,711K Shares Outstanding. Currently, annual sales are 0 K while annual income is -129,870 K. The company’s previous quarter sales were 0 K while its latest quarter income was -17,580 K.
